SCHEMBL161397

SCHEMBL161397

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 3/20 1.00
NR1H3 Q13133 3/20 0.83
POLA1 P09884 1/20 0.74
OSBP P22059 3/20 0.71
USP2 O75604 2/20 0.71
RORC P51449 2/20 0.71
LMNA P02545 1/20 0.71
ABCB1 P08183 1/20 0.71
OSBP2 Q969R2 1/20 0.71
GRIN2A Q12879 2/20 0.63
GRIN2D O15399 1/20 0.63
GRIN2B Q13224 1/20 0.63
GRIN2C Q14957 1/20 0.63
GRIN1 Q05586 1/20 0.61
GBA1 P04062 2/20 0.60
UGCG Q16739 2/20 0.60
GBA2 Q9HCG7 2/20 0.60
NPC1L1 Q9UHC9 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3509637 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL2304848 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL192029 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL25063545 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL22077526 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL25063542 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL16248291 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL21334348 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL21824301 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL29094045 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6732 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026099917-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, AND DEVICE FOR PRODUCING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
WO-2026101699-A1 LIPID NANOPARTICLE FORMULATIONS, AND METHODS OF USE THEREOF R.P. SCHERER TECHNOLOGIES, LLC (US) 2026-05-15 WO claimed
EP-4734964-A1 LIPID PARTICLES FOR DELIVERING A PAYLOAD Repertoire Immune Medicines, Inc. (US) 2026-05-06 EP claimed
US-20260115129-A1 METHOD FOR INCREASING EFFECTIVE POLYPHENOL COMPONENTS USING HIGH-TEMPERATURE AND PRESSURIZATION STEAM EXTRACTION METHOD SUMSUMBIOCO LTD (KR) 2026-04-30 US claimed
WO-2026089660-A1 A PLATFORM FOR MIMICKING BIOLOGICAL AIR-INTERFACES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2026-04-30 WO claimed
EP-4731197-A1 LIPOSOMAL-BASED COMPOSITION Consejo Superior De Investigaciones Científicas (ES) 2026-04-29 EP claimed
US-12599547-B2 Topical compositions optimised for epidermal lipids and phosphatidyl gycerol UNIFARCO S.P.A. (IT) 2026-04-14 US claimed
WO-2025202997-A1 AN ANTI-AGING EYE CREAM L'OREAL (FR) 2025-10-02 WO claimed
US-20250302721-A1 ANTI-AGING EYE CREAM L'OREAL (FR) 2025-10-02 US claimed
US-4906477-A Antineoplastic agent-entrapping liposomes KABUSHIKI KAISHA VITAMIN KENKYUSYO (JP) 1990-03-06 US claimed
WO-1990001323-A1 METHOD AND COMPOSITION FOR TREATING AND PREVENTING DRY SKIN DISORDERS BERNSTEIN JOEL E (US) 1990-02-22 WO claimed
EP-0303683-A4 AMPHOTERICIN B/CHOLESTEROL SULFATE COMPOSITION AND METHOD. LIPOSOME TECHNOLOGY INC (US) 1989-12-28 EP claimed
US-4822777-A MORE STABLE PARTICLE SIZE, LESS TOXIC LIPOSOME TECHNOLOGY, INC. (US) 1989-04-18 US claimed
EP-0303683-A1 AMPHOTERICIN B/CHOLESTEROL SULFATE COMPOSITION AND METHOD. LIPOSOME TECHNOLOGY INC (US) 1989-02-22 EP claimed
US-4780455-A PHOSPHOLIPIDS OR STEARINS WITH CHOLESTEROL SULFATE OR SODIUM CHOLESTEROL SULFATE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1988-10-25 US claimed
WO-1988006450-A1 AMPHOTERICIN B/CHOLESTEROL SULFATE COMPOSITION AND METHOD LIPOSOME TECHNOLOGY, INC. (US) 1988-09-07 WO claimed
EP-0278465-A1 Antineoplastic agent-entrapping liposomes Kabushiki Kaisha Vitamin Kenkyusyo (JP) 1988-08-17 EP claimed
EP-0265467-A1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS. OREAL (FR) 1988-05-04 EP claimed
WO-1987006499-A1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS L'OREAL (FR) 1987-11-05 WO claimed